
Legit.Health
Artificial Intelligence software for early detection, evaluation and monitoring of skin diseases.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
* | N/A | Early VC | |
Total Funding | 000k |
EUR | 2022 | 2023 |
---|---|---|
Revenues | 0000 | 0000 |
EBITDA | 0000 | 0000 |
Profit | 0000 | 0000 |
% profit margin | (1 %) | (119 %) |
EV | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x |
R&D budget | 0000 | 0000 |
Source: Company filings or news article
Related Content
Legit.Health, established in 2019 in Bilbao, Spain, is a digital health company developing clinical decision support tools for the dermatology sector. The company was co-founded by CEO Andy Aguilar, COO Taig Mac Carthy, Chief Artificial Intelligence Officer Alfonso Medela, and CTO Gerardo Fernandez. Medela’s interest in the field was sparked by personal frustrations with reactive healthcare, leading to his vision of a preventative system powered by artificial intelligence. His background includes a Bachelor's in Physics, a Master's in Physics from the University of Groningen, and a specialization in Big Data and Business Intelligence from the University of Deusto. Mac Carthy is a serial entrepreneur with a history of creating ventures since the age of 23, including a successful winery and a patented weight management aid, and has authored two business books.
The company operates on a Software-as-a-Service (SaaS) business model, marketing its CE-marked and ISO 13486 compliant medical device to healthcare professionals and organizations. Legit.Health's platform utilizes computer vision and artificial intelligence to assist dermatologists in diagnosing, monitoring, and managing over 320 different skin conditions. The technology allows healthcare providers to use smartphone images to assess pathologies, measure severity with automated scoring systems like PASI and SCORAD, and monitor treatment progress. This is designed to enhance diagnostic accuracy, streamline workflows, and improve the adequacy of patient referrals. The platform features a patient and doctor app for easy photo uploads and data access, as well as an Image Quality Check to ensure images are clinically useful.
Legit.Health serves a range of clients, including hospitals, insurance providers, and pharmaceutical companies. It has been clinically validated in Spanish hospitals such as the University Hospital of Torrejón, Cruces Hospital, and Basurto Hospital. The firm has established partnerships with entities like Ribera Salud, DKV, and Aptar Digital Health, integrating its technology to improve patient care and adherence. The company has secured funding from investors including Angels Capital, Grupo Ribera, Mutua Ventures, and Ship2B through several seed rounds. Legit.Health has received numerous awards, including the Emprende XXI Award in March 2024 and was named a winner at the South Summit in 2023.
Keywords: dermatology AI, clinical decision support, computer vision, skin disease diagnosis, medical imaging software, SaaS, digital health, teledermatology, automatic severity scoring, patient monitoring, CE-marked medical device, ISO 13486, clinical data tools, healthcare technology, Ribera Salud partner, DKV partner, Alfonso Medela, Taig Mac Carthy, Andy Aguilar, Gerardo Fernandez